C Antozzi
Overview
Explore the profile of C Antozzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
868
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pasqualin F, Guidoni S, Albertini E, Ermani M, Frangiamore R, Vanoli F, et al.
Neurol Sci
. 2022 Feb;
43(7):4503-4509.
PMID: 35226211
Objective: The aim of our study was to validate the Myasthenia Gravis TeleScore (MGTS), a scale for the evaluation of MG patients in telemedicine. Introduction: COVID-19 pandemic has boosted telemedicine...
2.
Stabile A, Deleo F, Didato G, Pastori C, Antozzi C, de Curtis M, et al.
Eur J Neurol
. 2018 Nov;
25(12):e125-e126.
PMID: 30403325
No abstract available.
3.
Farago G, Caldiera V, Antozzi C, Bellino A, Innocenti A, Ciceri E
Eur Radiol
. 2016 Aug;
27(5):2200-2205.
PMID: 27565801
Objectives: Spinal dural arteriovenous fistulas (SDAVFs) are acquired diseases that represent the majority of all arteriovenous spinal shunts, leading to progressive and disabling myelopathy. Treatment is focused on accurately disconnecting...
4.
Brambilla L, Rossi Sebastiano D, Aquino D, Torri Clerici V, Brenna G, Moscatelli M, et al.
J Neurol Sci
. 2016 Aug;
368:402-7.
PMID: 27538672
Background: 4-aminopyridine (4-AP) is a potassium-channel blocker able to enhance walking speed in MS improving the action potentials of demyelinated axons on which internodal potassium channels are exposed. Objective: to...
5.
Stergiou C, Lazaridis K, Zouvelou V, Tzartos J, Mantegazza R, Antozzi C, et al.
J Neuroimmunol
. 2016 Mar;
292:108-15.
PMID: 26943968
Myasthenia gravis (MG) is an autoimmune disease caused by antibodies targeting the neuromuscular junction of skeletal muscles. Triple-seronegative MG (tSN-MG, without detectable AChR, MuSK and LRP4 antibodies), which accounts for...
6.
Tsonis A, Zisimopoulou P, Lazaridis K, Tzartos J, Matsigkou E, Zouvelou V, et al.
J Neuroimmunol
. 2015 May;
284:10-7.
PMID: 26025053
Seronegative myasthenia gravis (MG) presents a serious gap in MG diagnosis and understanding. We applied a cell based assay (CBA) for the detection of muscle specific kinase (MuSK) antibodies undetectable...
7.
Zisimopoulou P, Evangelakou P, Tzartos J, Lazaridis K, Zouvelou V, Mantegazza R, et al.
J Autoimmun
. 2013 Dec;
52:139-45.
PMID: 24373505
Double-seronegative myasthenia gravis (dSN-MG, without detectable AChR and MuSK antibodies) presents a serious gap in MG diagnosis and understanding. Recently, autoantibodies against the low-density lipoprotein receptor-related protein 4 (LRP4) have...
8.
Cavalcante P, Barberis M, Cannone M, Baggi F, Antozzi C, Maggi L, et al.
Neurology
. 2010 Apr;
74(14):1118-26.
PMID: 20368632
Background: Genetic and environmental factors are thought to contribute to the etiology of the autoimmune disease myasthenia gravis (MG). Viral involvement has long been suspected, but direct evidence of involvement...
9.
Antozzi C, Frassoni C, Vincent A, Regondi M, Andreetta F, Bernasconi P, et al.
Neurology
. 2005 Apr;
64(7):1290-3.
PMID: 15824370
A patient with thymoma-associated neuromyotonia and voltage-gated potassium channel (Kv1.2 and Kv1.6) antibodies by immunoprecipitation and rat brain immunolabeling was treated successfully with immunoadsorption and cyclophosphamide. Curiously, glutamic acid decarboxylase...
10.
Bien C, Granata T, Antozzi C, Cross J, Dulac O, Kurthen M, et al.
Brain
. 2005 Feb;
128(Pt 3):454-71.
PMID: 15689357
Rasmussen encephalitis (RE) is a rare but severe immune-mediated brain disorder leading to unilateral hemispheric atrophy, associated progressive neurological dysfunction and intractable seizures. Recent data on the pathogenesis of the...